These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 10839330)

  • 21. Decisional capacity of patients with schizophrenia to consent to research: taking stock.
    Appelbaum PS
    Schizophr Bull; 2006 Jan; 32(1):22-5. PubMed ID: 16177275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Dunn LB; Appelbaum PS; Jeste DV
    Arch Gen Psychiatry; 2004 Mar; 61(3):230-6. PubMed ID: 14993110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Informed consent: assessment of comprehension.
    Wirshing DA; Wirshing WC; Marder SR; Liberman RP; Mintz J
    Am J Psychiatry; 1998 Nov; 155(11):1508-11. PubMed ID: 9812110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informed consent and neuroanatomic correlates of intentionality and voluntariness among psychiatric patients.
    Grimes AL; McCullough LB; Kunik ME; Molinari V; Workman RH
    Psychiatr Serv; 2000 Dec; 51(12):1561-7. PubMed ID: 11097654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
    Wu BJ; Liao HY; Chen HK; Lan TH
    Psychiatry Res; 2016 Mar; 237():323-30. PubMed ID: 26847945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia.
    Dunn LB; Palmer BW; Appelbaum PS; Saks ER; Aarons GA; Jeste DV
    Schizophr Res; 2007 Jan; 89(1-3):110-8. PubMed ID: 17020803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sense and nonsense: an essay on schizophrenia research ethics.
    Carpenter WT; Conley RR
    Schizophr Res; 1999 Feb; 35(3):219-25; discussion 227-36. PubMed ID: 10093866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decisional capacity of severely depressed patients requiring electroconvulsive therapy.
    Lapid MI; Rummans TA; Poole KL; Pankratz VS; Maurer MS; Rasmussen KG; Philbrick KL; Appelbaum PS
    J ECT; 2003 Jun; 19(2):67-72. PubMed ID: 12792453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of individual cognitive abilities to specific components of decisional capacity among middle-aged and older patients with schizophrenia.
    Palmer BW; Jeste DV
    Schizophr Bull; 2006 Jan; 32(1):98-106. PubMed ID: 16192412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testing decision-making competency of schizophrenia participants in clinical trials. A meta-analysis and meta-regression.
    Hostiuc S; Rusu MC; Negoi I; Drima E
    BMC Psychiatry; 2018 Jan; 18(1):2. PubMed ID: 29304845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capacity to consent to research in schizophrenia: the expanding evidence base.
    Dunn LB
    Behav Sci Law; 2006; 24(4):431-45. PubMed ID: 16883608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing informed consent for research and treatment.
    Dunn LB; Jeste DV
    Neuropsychopharmacology; 2001 Jun; 24(6):595-607. PubMed ID: 11331139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The need for additional safeguards in the informed consent process in schizophrenia research.
    Anderson KK; Mukherjee SD
    J Med Ethics; 2007 Nov; 33(11):647-50. PubMed ID: 17971467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the capacity to express informed consent for organ donation in patients with schizophrenia.
    De Marco MC; Sani G; Manfredi G; Pacchiarotti I; Savoja V; Balbi A; Mazzarini L; Borriello A; Kotzalidis GD; Tatarelli R; Girardi P; Ferracuti S
    J Forensic Sci; 2010 May; 55(3):669-76. PubMed ID: 20345780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decisional capacity and consent for schizophrenia research.
    Kaup AR; Dunn LB; Saks ER; Jeste DV; Palmer BW
    IRB; 2011; 33(4):1-9. PubMed ID: 21932481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competence to consent and insight in schizophrenia: is there an association? A pilot study.
    Capdevielle D; Raffard S; Bayard S; Garcia F; Baciu O; Bouzigues I; Boulenger JP
    Schizophr Res; 2009 Mar; 108(1-3):272-9. PubMed ID: 19162443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of decisional capacity: Prevalence of medical illness and psychiatric comorbidities.
    Boettger S; Bergman M; Jenewein J; Boettger S
    Palliat Support Care; 2015 Oct; 13(5):1275-81. PubMed ID: 25355466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decision-making capacity for research participation among addicted people: a cross-sectional study.
    Morán-Sánchez I; Luna A; Sánchez-Muñoz M; Aguilera-Alcaraz B; Pérez-Cárceles MD
    BMC Med Ethics; 2016 Jan; 17():3. PubMed ID: 26759171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.
    Stroup TS; Appelbaum PS; Gu H; Hays S; Swartz MS; Keefe RS; Kim SY; Manschreck TC; Boshes RA; McEvoy JP; Lieberman JA
    Schizophr Res; 2011 Aug; 130(1-3):47-52. PubMed ID: 21561740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.
    Dunn LB; Kim DS; Fellows IE; Palmer BW
    Schizophr Bull; 2009 Jul; 35(4):730-7. PubMed ID: 18281293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.